<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04998071</url>
  </required_header>
  <id_info>
    <org_study_id>REC.015/2564</org_study_id>
    <nct_id>NCT04998071</nct_id>
  </id_info>
  <brief_title>Posterior Quadratus Lumborum Block Using 0.125% Versus 0.25% Bupivacaine for Analgesia in Children Undergoing LPEC</brief_title>
  <official_title>Comparison of Analgesic Efficiency in Laparoscopic Percutaneous Extraperitoneal Closure for Pediatric Inguinal Hernia and Hydrocele Provided by Ultrasound Guided Posterior Quadratus Lumborum Block Using Between 0.125% and 0.25% Bupivacaine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen Sirikit National Institute of Child Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Queen Sirikit National Institute of Child Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to evaluate and compare the analgesic efficiency of the&#xD;
      difference concentration between 0.125% and 0.25% bupivacaine provided by ultrasound guided&#xD;
      posterior quadratus lumborum block undergoing LPEC in children&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fifty participants both male and female aged from 1 to 6 years old, AGED FROM 1 TO 6 YEARS&#xD;
      OLD, ASA class I to II undergoing elective Laparoscopic percutaneous extraperitoneal closure&#xD;
      for pediatric inguinal hernia and hydrocele will be randomly divided into two equal groups of&#xD;
      twenty five by using computer generated random table.&#xD;
&#xD;
      All received premedication in the form of midazolam 0.1 mcg/kg IV. Perioperative monitoring&#xD;
      included continuous ECG, NIBP and pulse oximetry. Baseline reading of these were recorded.&#xD;
      General anesthesia will be inducted using thiopental 5 mg/kg then atracurium 0.5 mg/kg to&#xD;
      facilitate endotracheal tube intubation and fentanyl 1 mcg/kg. Anesthesia will be maintained&#xD;
      using 2% isoflurane with oxygen to air 40:60.&#xD;
&#xD;
      Posterior quadratus lumborum block (The technique which local anesthetic agent is injected at&#xD;
      middle thoracolumbar fascia between erector spina muscle and quadratus lumborum muscle)&#xD;
      provided by GE, LOGIQe VERSION (12L-RS, LINEAR ARRAY) ultrasound guided and using stimuplex&#xD;
      needle 22G-2 inches on both sides under sterile technique in lateral position will be&#xD;
      performed in all patients immediately after induction and before starting surgery. patients&#xD;
      will be allocated randomly into two equal groups, twenty five in each as the following GROUP&#xD;
      1 will receive 0.25% bupivacaine 0.4 ml/kg. per each side. GROUP 2 will receive 0.125%&#xD;
      bupivacaine 0.4 ml/kg. per each side. The patients and parents along with independent&#xD;
      anesthesiologist and attending nurses were not aware of group allocation.&#xD;
&#xD;
      The surgical intervention was started not less than 10 minutes after block. Pneumoperitonium&#xD;
      pressure was limited not exceed 10 mmHg. After completion of surgery, anesthesia was&#xD;
      discontinued and muscle relaxant was reversed as usual. After extubation, the patients will&#xD;
      be transfer to PACU.&#xD;
&#xD;
      Postoperative pain will be assessed by attending nurses, using CHEOPs SCORE. Acetaminophen 10&#xD;
      mg/kg. orally will be given as rescue analgesia for patient with CHEOPs SCORE more than 6.&#xD;
      Parameters will be assessed&#xD;
&#xD;
      Intraoperative measurements:&#xD;
&#xD;
        1. Hemodynamic parameters: HR and MAP were recorded before, immediately and every 5 minutes&#xD;
           after induction of anesthesia until the end of the operation.&#xD;
&#xD;
        2. Analgesic requirement: All through the procedure (By measure analgesic need&#xD;
           intraoperative in the form of fentanyl 0.5 mcg/kg) In case of increase in intraoperative&#xD;
           MAP or HR of more than 20% from baseline.&#xD;
&#xD;
        3. Incidence of complications: In the form of hypotension, hematoma, intraabdominal organ&#xD;
           injury LAST.&#xD;
&#xD;
      Postoperative measurements:&#xD;
&#xD;
        1. Quality of analgesia: Assessed immediately postoperatively every 30 minutes in the PACU&#xD;
           and then at 4, 8, 12 hours at ward using CHEOPs SCORE and 24 hours postoperatively using&#xD;
           PARENT'S POSTOPERATIVE PAIN MEASUREMENT(PPPM).&#xD;
&#xD;
        2. Incidence of complications: In the form assessment of intensity of motor block by using&#xD;
           MODIFIED BROMAGE SCORE, vomiting and hemodynamic instability.&#xD;
&#xD;
        3. Others: In the form of parent's satisfaction of analgesia and length of hospital stay.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 15, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of postoperative analgesia</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Postoperative pain score as CHEOPs SCORE</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of complications</measure>
    <time_frame>12 hours after surgery</time_frame>
    <description>Intensity of motor block by using MODIFIED BROMAGE SCORE, vomiting and hemodynamic instability</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>ROUTINE DRUG - CONCENTRATION QLB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will receive bilateral posterior quadratus lumborum block using 0.25% bupivacaine 0.4 ml/kg. in each side.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ALTERNATIVE DRUG - CONCENTRATION QLB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will receive bilateral posterior quadratus lumborum block using 0.125% bupivacaine 0.4 ml/kg. in each side.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine hydrochloride</intervention_name>
    <description>Analgesic efficiency comparison between two concentration of bupivacaine hydrochloride using for posterior quadratus lumborum block in LPEC</description>
    <arm_group_label>ALTERNATIVE DRUG - CONCENTRATION QLB</arm_group_label>
    <arm_group_label>ROUTINE DRUG - CONCENTRATION QLB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children scheduled for laparoscopic percutaneous extraperitoneal closure(LPEC) for&#xD;
             pediatric inguinal hernia and hydrocele&#xD;
&#xD;
          -  ASA I-II physical status patients&#xD;
&#xD;
          -  Complete inform consent for intervention&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication for regional anesthesia&#xD;
&#xD;
          -  Sensitive to local anesthetic agent, opioid or acetaminophen&#xD;
&#xD;
          -  Previous history of abdominal surgery&#xD;
&#xD;
          -  History of neuromuscular disease&#xD;
&#xD;
          -  G6PD deficiency&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SUWITCHA TAMRONGCHOTE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen Sirikit National Institute of Child Health (QSNICH)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>SUWITCHA TAMRONGCHOTE, MD</last_name>
    <phone>+66989425629</phone>
    <email>S.NI.KTAMP@GMAIL.COM</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>NUTTAPHONG LEPANANON, MD</last_name>
    <phone>+66850602800</phone>
    <email>N_PEDIAN@HOTMAIL.COM</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Queen Sirikit National Institute of Child Health</name>
      <address>
        <city>Ratchathewi</city>
        <state>Bangkok</state>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kullasate Sakpichaisakul, MD</last_name>
      <email>kullasate.s@rsu.ac.th</email>
    </contact>
    <contact_backup>
      <last_name>Kantapon Trongkamolchai, MD</last_name>
      <email>kantapon260619870@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Kullasate Sakpichaisakul, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kantapon Trongkamolchai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Somjit Sri-udomkajorn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sirorat Suwannachote, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ravivan Wittawassamrankul, R Ph</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ravindra Arya, MD, DM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Suwitcha Tamrongchote, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 9, 2021</study_first_submitted>
  <study_first_submitted_qc>August 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2021</study_first_posted>
  <last_update_submitted>August 1, 2021</last_update_submitted>
  <last_update_submitted_qc>August 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen Sirikit National Institute of Child Health</investigator_affiliation>
    <investigator_full_name>Kullasate Sakpichaisakul</investigator_full_name>
    <investigator_title>Queen Sirikit National Institute of Child Health</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

